OCULAR THERAPEUTIX INC's ticker is OCUL and the CUSIP is 67576A100. A total of 114 filers reported holding OCULAR THERAPEUTIX INC in Q3 2023. The put-call ratio across all filers is 0.46 and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $656,982 | -83.9% | 209,230 | -73.6% | 0.00% | – |
| Q2 2023 | $4,084,145 | +8.7% | 791,501 | +11.0% | 0.00% | – |
| Q1 2023 | $3,758,453 | +242.6% | 713,179 | +82.7% | 0.00% | – |
| Q4 2022 | $1,097,013 | -66.3% | 390,396 | -50.2% | 0.00% | – |
| Q3 2022 | $3,252,000 | +424.5% | 783,705 | +408.2% | 0.00% | – |
| Q2 2022 | $620,000 | -64.8% | 154,220 | -56.6% | 0.00% | – |
| Q1 2022 | $1,759,000 | -77.1% | 355,227 | -67.7% | 0.00% | – |
| Q4 2021 | $7,672,000 | -6.7% | 1,100,774 | +33.8% | 0.00% | -100.0% |
| Q3 2021 | $8,226,000 | -34.2% | 822,600 | -6.7% | 0.00% | -50.0% |
| Q2 2021 | $12,506,000 | +17.4% | 881,970 | +35.8% | 0.00% | 0.0% |
| Q1 2021 | $10,655,000 | -27.3% | 649,323 | -8.3% | 0.00% | +100.0% |
| Q4 2020 | $14,654,000 | +291.8% | 707,920 | +44.1% | 0.00% | – |
| Q3 2020 | $3,740,000 | -23.1% | 491,440 | -15.9% | 0.00% | – |
| Q2 2020 | $4,865,000 | +198.8% | 584,038 | +77.7% | 0.00% | – |
| Q1 2020 | $1,628,000 | +121.8% | 328,661 | +76.8% | 0.00% | – |
| Q4 2019 | $734,000 | +40.3% | 185,932 | +8.0% | 0.00% | – |
| Q3 2019 | $523,000 | -84.4% | 172,235 | -77.4% | 0.00% | – |
| Q2 2019 | $3,354,000 | +1339.5% | 762,225 | +1202.9% | 0.00% | – |
| Q1 2019 | $233,000 | -75.6% | 58,500 | -75.6% | 0.00% | – |
| Q4 2018 | $954,000 | -45.1% | 239,714 | -5.1% | 0.00% | – |
| Q3 2018 | $1,737,000 | +26.4% | 252,529 | +24.0% | 0.00% | – |
| Q2 2018 | $1,374,000 | -0.7% | 203,672 | -4.1% | 0.00% | – |
| Q1 2018 | $1,383,000 | +73.1% | 212,400 | +18.3% | 0.00% | – |
| Q4 2017 | $799,000 | -45.2% | 179,602 | -23.9% | 0.00% | – |
| Q3 2017 | $1,458,000 | -42.3% | 235,897 | -13.5% | 0.00% | – |
| Q2 2017 | $2,529,000 | -26.7% | 272,777 | -26.7% | 0.00% | -100.0% |
| Q1 2017 | $3,451,000 | +60.1% | 371,900 | +44.4% | 0.00% | – |
| Q4 2016 | $2,155,000 | +10.0% | 257,485 | -9.7% | 0.00% | -100.0% |
| Q3 2016 | $1,959,000 | +258.1% | 285,200 | +158.1% | 0.00% | – |
| Q2 2016 | $547,000 | -27.4% | 110,500 | +41.7% | 0.00% | – |
| Q1 2016 | $753,000 | +216.4% | 78,000 | +207.6% | 0.00% | – |
| Q4 2015 | $238,000 | -78.7% | 25,355 | -68.0% | 0.00% | – |
| Q3 2015 | $1,115,000 | – | 79,300 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SUMMER ROAD LLC | 3,804,788 | $15,105,000 | 43.34% |
| Versant Venture Management, LLC | 2,215,384 | $8,795,074,000 | 2.90% |
| Opaleye Management Inc. | 1,900,000 | $7,543,000 | 2.09% |
| SV Health Investors, LLC | 628,236 | $2,494,000 | 1.46% |
| Endurant Capital Management LP | 716,124 | $2,843,000 | 1.12% |
| DELTEC ASSET MANAGEMENT LLC | 824,747 | $3,274,000 | 0.72% |
| NOTTINGHAM ADVISORS, INC. | 146,946 | $583,000 | 0.08% |
| Jump Trading, LLC | 39,255 | $156,000 | 0.05% |
| Man Group plc | 1,723,456 | $6,842,000 | 0.03% |
| JGP Global Gestao de Recursos Ltda. | 13,880 | $55,000 | 0.02% |